Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Omeros selects clinical candidate for MASP-2 antibody program

May 14, 2010

Osiris achieves milestone for remestemcel-L development progress in Japan

April 29, 2010

DMC recommends continued enrollment in eritoran phase III trial for severe sepsis

March 26, 2010

Phase I trial of deferoxamine in acute cerebral hemorrhage currently recruiting participants

March 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...